Could your workout breathing harm your eyes? new study investigates
NCT ID NCT07326462
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how different breathing patterns during strength exercises change eye pressure and blood flow in the retina. Sixty healthy adults aged 18-40 will perform exercises with normal breathing or a breath-holding technique called the Valsalva maneuver. Researchers will measure eye pressure, retinal vessel size, and other health markers before and after exercise to find the safest way to train.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could help design safer exercise routines for people with eye conditions like glaucoma.
- What could go wrong
- This is a small, early-stage study in healthy volunteers, so results may not apply to people with eye diseases. The findings are observational and won't directly lead to a treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 60 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jan 2026
An estimate. Start dates often move.
- Expected to finish
-
May 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 40 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Subjects 18-40 years old 2. Peak IOP \<21 mmHg in the modified DTC 3. Open angle at gonioscopy 4. Optic disc with cup-to-disc ratio \<0.6 with no signs of glaucomatous neuropathy 5. Not currently taking any medication 6. Non-smokers, no physical and mental disabilities 7. Blood pressure up 120/80 mmHg and heart rate (HR) 60-90 rpm at rest 8. BMI (18.5-34.8) kg/m2 Exclusion Criteria: 1. Presence of any ocular disease (with the exception of refractive errors) 2. Anxiety or depressive disorders 3. History of ocular trauma or surgery 4. Pregnancy 5. Use of any kind of oral/topical steroids 6. Any diagnosed chronic health condition such as cardiovascular disease including hypertension and or previous physical injuries that could impact their safe participation 7. Evidence of ocular pathology due to narrow anterior chamber angles, elevated IOP greater than or equal to 21mm Hg, optic nerve or retinal pathology, cup: disc ratio of greater than 0.6 or asymmetry of cup: disc ratio of greater than 0. 2. 8. Refractive error more than ±4.00 diopters, astigmatism greater than 3.00 diopters.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Healthy participants are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Does it matter where you inject? scientists test Weight-Loss drug in arm, thigh, and belly
- New drug RO7830698 put to the test for COPD
- Three pill versions of one drug go head to head in the bloodstream
- Pfizer tests RSV vaccine aimed at older adults
- Radioactive tracer maps where a new drug goes in the body
- Radioactive tag lets scientists follow an experimental drug through the human body